Trump threatens to disclose 'devastating' secret info

New Post Public Reply Private Reply Replies (1) Message Board

Nov 29, 2018 at 11:15 AM 177

Quote:

Trump threatens to disclose 'devastating' secret info (which may not exist)

11/29/18 08:00 AM—Updated 11/29/18 08:08 AM
By Steve Benen

The day after the midterm elections, Donald Trump held a press conference in which he expressed some anxiety about congressional investigations from House Democrats.

The president threatened to expose “very questionable things” unnamed Dems have done, adding that he wouldn’t work with Congress on substantive issues if he disapproved of lawmakers’ oversight.

Yesterday, in an interview with the New York Post, Trump went a little further.

In a wide-ranging, exclusive interview with The Post, President Trump said Wednesday that if House Democrats launched probes into his administration – which he called “presidential harassment” – they’d pay a heavy price.

“If they go down the presidential harassment track, if they want go and harass the president and the administration, I think that would be the best thing that would happen to me. I’m a counter-puncher and I will hit them so hard they’d never been hit like that,” he said during a 36-minute Oval Office sitdown.

Specifically, the president reportedly raised the prospect with the New York Post of declassifying materials related to Special Counsel Robert Mueller’s investigation of the Russia scandal, which he predicted would expose some kind of conspiracy linking the FBI, the Justice Department, and Hillary Clinton’s 2016 campaign.

Democrats, Trump warned, “will see how devastating those pages are.”

He’s evidently not prepared to share this evidence now. Rather, the president wants the incoming Democratic House majority to believe he has leverage: if they investigate him, Trump will offer proof to substantiate his anti-Justice Department conspiracy theories.

If, right about now, you find yourself smirking and struggling to stifle a laugh, rest assured, you’re not alone.

On the surface, it’s hard not to notice that Trump seems awfully concerned about House Democratic scrutiny of his White House.

Most modern presidents have had to deal with the opposition party controlling at least part of Congress, but no modern presidents have scrambled to publicly threaten lawmakers not to investigate executive-branch scandals.

I wonder why this is making him so nervous.

There’s also a degree of irony to the circumstances: in the same interview yesterday, Trump railed against “McCarthyism.” It created an unfortunate dynamic: the president simultaneously condemned the tactics of Joseph McCarthy and claimed to have “devastating” secret information that would embarrass his perceived political enemies – which, of course, was a standard McCarthy tactic.

Also a tactic admired by and employed by some credulous wishful thinkers who post unsubstantiated nonsense on this board.

But perhaps most important is the familiarity of the circumstances. Trump claimed to have secret information about Sen. Jon Tester (D-Mont.) that would end his career, but that information didn’t exist.

Trump claimed that by declassifying secret intelligence related to the Mueller probe, he could bolster Republican talking points. This tactic has already failed – twice.

It’s against this backdrop that Trump expects everyone to believe that he’s again sitting on secret information that would substantiate one of his favorite conspiracy theories, and he’ll release the “devastating” materials if Congress investigates his scandals.

I have a hunch the incoming House Democratic majority isn’t overly concerned.

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fault Codes vs. Diagnosis: What's the Real Fix?

When a Blink Isn’t the Whole Story Ever sat in your car, watched that check engine light flicker on, and felt your heart drop? Yeah, we've all been there. But here’s the kicker: just ‘cause that little demon’s glowing doesn’t mean your mechanic’s got all the answers. That’s where this HelloNation article steps in, trying to shed some light on the difference...

Altitude+ and ViewLift Celebrate Record Fan Engagement

Fresh Off the Bench: Altitude+ Rises Picture this: you're cruising through October, watching the leaves fall and the puck drop, and here come Altitude+ and ViewLift boasting some record numbers. This ain't your everyday puff piece — they've got concrete results to back it up. Altitude+, charging into the 2026–27 NHL and NBA seasons, isn't just surviving; they're...

Venezuelan Crude Hits Texas: NABEP's Bold Move

Venezuelan Crude Docking in Texas Signals New Energy Dynamics Batten down the hatches, 'cause NABEP's Venezuelan crude has made a splashy arrival in Texas. We're talking 1 million barrels, folks, the first of its kind under a fresh U.S. deal. This ain't your grandpa's oil shipment from the Middle East that takes forever to get here—nope, this crude made a pit stop in...

Heart Attack vs. Cardiac Arrest: Know the Differences

Spotting the Crisis: Heart Attack or Cardiac Arrest? When your heart’s in trouble, knowing whether it’s a heart attack or cardiac arrest isn’t just some medical trivia—it could save a life. According to healthcare whiz Justin Doss from Beaumont, Texas, this difference can be the thin line between life and a dire outcome. What's the Deal with These Heart Events?...

Lincoln Educational Faces Class Action for Stock Drop

What's Gripping Lincoln Educational Services? You ever feel like you've stepped into a financial thriller with these education stocks? Well, Lincoln Educational Services (NASDAQ:LINC) is at the heart of one, facing the heat of a class action lawsuit filed by Bleichmar Fonti & Auld LLP. It's all about securities fraud—a dreaded term that no investor wants to hear. The...

Yuchai Eyes African Market Expansion with Strategic Visits

Yuchai's Bold Move into Africa There's something gutsy about a company that doesn't just sit on its achievements but heads out into new territories. China Yuchai International (NYSE: CYD), a big player in powertrain solutions, recently embarked on a strategic tour across the African continent, a move that could well shape their future market playbook. East Africa:...

Americans' Faith in Democracy Hits New Lows

Polarization Beyond Politics: A National Reckoning When you catch wind of a report like this one, it's enough to make you feel like the fabric of democracy is unraveling right before our eyes. We're staring at a national identity crisis, folks, and it's got nothing to do with whether you're waving a red or blue flag. This ain't about party lines; it's about a bigger,...

Franklin Financial Q3: 59% Net Income Surge Amid Growth

Soaring Net Income and Impressive Growth Franklin Financial Services Corporation (NASDAQ: FRAF) seems to be on a roll this year, painting a vivid picture of growth as they close out the third quarter of 2026. With a strong surge in net income—59.4% up from Q3 2025—this leadership in earnings is no fluke. Net Income and Earnings per Share Let's break it down: the...

Alpheus Explores LDH Kinetics as Glioblastoma Biomarker

Cracking Glioblastoma's Tough Shell Some days, you're slogging through numbers that don't add up, and other times, you stumble upon findings that just might change the game. Alpheus Medical, diving headfirst into the murky waters of glioblastoma, dropped some intriguing data at the ESMO Congress 2026. This isn't your usual round of clinical discoveries, folks. What...

Post University Expands with New Tech and Health Degrees

If you're looking to invest in an education with promising payoffs, you might look into what's cooking over at Post University. They've just dropped a bombshell of new programs sure to get some attention from tech heads and health nuts alike, and I can't help but think there's potential brewing here. New Academic Paths Emerge Post University isn't resting on its...

Top 5 Most Recently Viewed Articles

T1D Fund's Major Capital Raise for Revolutionary Diabetes Solutions

Launch of a Transformative Capital Raise by the T1D Fund The T1D Fund has embarked on an exciting new fundraising initiative designed to supercharge investment in groundbreaking solutions for type 1 diabetes (T1D). This fundraising campaign is tailored to stimulate larger, more substantial investments in innovative T1D programs, thanks to the Fund's renowned track record...

NEST Center's Exciting Renovation Plans Unveiled for Tenants

Major Renovation Kickoff at the Northeast Science & Technology Center The Northeast Science & Technology (NEST) Center is launching an ambitious renovation project, aimed at enhancing over 75,000 square feet of shared amenities designed to foster a vibrant ecosystem of research and innovation for both current and future tenants. Innovative Vision for the NEST Center...

Understanding Tryg's Share Buyback Programme Dynamics

Detailed Insights on Tryg's Share Buyback Programme In a strategic move, Tryg A/S has initiated a robust share buyback programme aimed at enhancing shareholder value. This initiative, valued at up to DKK 2.0 billion, signifies Tryg's commitment to boosting the long-term interests of its shareholders. Understanding the Share Buyback Programme The share buyback programme,...

ST Imaging's ViewScan Earns 11th Platinum Library Award

ST Imaging's ViewScan Reigns Supreme at Modern Library Awards In a remarkable achievement for innovation in library technology, ST Imaging's ViewScan 4 has earned the prestigious Platinum Modern Library Award for the eleventh consecutive year. This award, given by LibraryWorks, celebrates excellence in products designed specifically for library environments, and ST...

Gilead Sciences Insider Moves Spark Investor Interest

Insider Activity at Gilead Sciences: Key Updates Recently, a significant transaction was reported by Jeffrey Bluestone, a Board Member at Gilead Sciences (NASDAQ: GILD). In a filing with the SEC, it was revealed that Bluestone exercised stock options for a total of 5,000 shares. This transaction was valued at $296,250, drawing important attention from investors and market...